Cardiac tumors, although rare, carry high morbidity and mortality rates. They are commonly
first identified either at echocardiography or incidentally at thoracoabdominal CT performed …

Purpose Characterization of malignant cardiac masses is usually performed with cardiac
magnetic resonance (CMR) and staging with whole-body contrast-enhanced computed …

Background Cardiac masses are rare with high morbidity and mortality that challenging the
management. The purpose of this study was to evaluate the potential role of cardiac-MRI …

Generally, cardiac masses are initially suspected on routine echocardiography. Cardiac
magnetic resonance (CMR) imaging is further performed to differentiate tumors from pseudo …

Intracardiac masses are classified as neoplastic or non-neoplastic. Prognosis varies based
on the diagnosis of the mass since treatment options differ greatly. As novel imaging …

PRIMARY CARDIAC TUMORS ARE RARE, WITH MYXOMA BEING THE MOST COMMON
BENIGN HISTOLOGY, whereas malignancies are usually sarcomatous (1). They are found …

Abstract Background 18 F-FDG PET/CT is a key molecular imaging modality to
noninvasively assess and differentiate benign and malignant cardiac tumors. However, few …

ABSTRACT A wide spectrum of masses can affect the heart, ranging from non-malignant
entities, such as thrombi, to aggressive primary cardiac tumors, such as angiosarcomas …

Cardiac and pericardial masses can be categorized as neoplastic (either benign or
malignant), non-neoplastic (such as thrombus or pericardial cysts), or normal variants of the …

Cardiac masses can be classified as neoplastic (pri-mary benign, primary malignant, and
metastatic), nonneoplastic (thrombi, vegetation, and calcifications), and pseudotumors …